Showing posts with label Canada. Show all posts
Showing posts with label Canada. Show all posts

Sunday, 6 September 2026

Canada: Calgary boy’s arthritis diagnosis highlights a disease many still associate only with old age

From ctvnews.ca

September is Arthritis Awareness Month in Canada, shining a spotlight on a disease that can affect far more than joints — and far more than older adults.

For Calgary’s Riley Ostrowski, the diagnosis came when he was just seven years old, after a frightening and confusing stretch of hospital visits, painful symptoms and months without answers.

He woke early one morning crying and unable to move his neck, prompting his family to take him to hospital.

“I feel like it just stopped all of my physical movement,” said Riley.

“I felt it in my ankles, my shoulders and my wrist and I wasn’t even able to walk up or down the stairs.”

Riley Ostrowski

What followed was a 12-day stay at Alberta Children’s Hospital, along with months of appointments, testing and uncertainty before Riley was eventually diagnosed with systemic juvenile idiopathic arthritis, or systemic JIA.

Riley’s mother, Jennifer Schultz, says that at its worst, the disease affected as many as 14 of her son’s joints.

“He experienced high fevers, rashes, fatigue, and pain and until this happened, we had no clue kids could get arthritis,” she said.

“It took about four months to get the diagnosis, but the fact that we were able to get treated right away was a Godsend because some families have spent more than a year or two years before they got an answer.”

Riley’s mother, Jennifer Schultz, says that at its worst, the disease affected as many as 14 of her son’s joints

Riley was initially treated with anti-inflammatory medication and steroids before moving to biologic therapy.

His family says the medication made a dramatic difference.

“The treatments have been amazing and work very fast,” Schultz said.

Riley initially received treatment intravenously at Alberta Children’s Hospital every few weeks, but has since transitioned to injections at home.

His condition is now largely in remission, and he has returned to many of the activities he enjoys, including playing baseball.

“I sometimes feel like a normal kid. I was freaked out when I first started having to inject these needles, but I feel a lot stronger,” Riley said.

“I love playing baseball, writing comics, and playing video games. So if there are any other kids out there with juvenile arthritis, it’s the love of your family that makes you strong.”

What is juvenile idiopathic arthritis?

Dr. Marinka Twilt, a paediatric rheumatologist at Alberta Children’s Hospital and professor of paediatrics at the University of Calgary, says juvenile idiopathic arthritis is an autoimmune disease in which the immune system mistakenly attacks the body’s own tissues.

The exact cause is not known and is likely influenced by a combination of genetic and environmental factors.

“It’s nothing that a patient or parent has done wrong, and nothing that they could have prevented from it to happen,” Twilt said.

Juvenile arthritis affects an estimated one in 1,000 children.

Twilt says symptoms in children can sometimes be difficult to recognize because younger patients may adapt to pain rather than complain about it.

“They’ll just find another way to still do what they want to do,” she said.

Some children may stop using an affected joint, become unusually tired or lose the ability or willingness to do activities they previously enjoyed. Younger children may suddenly want to be carried more often or stop running and playing.

“If you see that there’s regression in what they could do before, that would be really a sign to go and see a health-care provider,” Twilt said.

Twilt says treatment options for juvenile arthritis have improved significantly, but awareness remains important because earlier diagnosis can help children access effective treatment sooner.

“Awareness is good for the patient that they’re earlier diagnosed, but then when they’re diagnosed, we have to have access to treatment,” she said.

Building support for families

Cassie + Friends, a Canadian charity supporting children with juvenile arthritis and other rheumatic diseases, says roughly 25,000 children across the country are living with those conditions.

“We really want people to understand that kids get arthritis too,” said David Porte, chair and one of the organization’s founders.

Porte helped establish Cassie + Friends after his own daughter, Cassie, was diagnosed with juvenile arthritis at 20 months old.

The organization now provides families with education, financial and emotional support while also connecting children with others facing similar diagnoses.

Cassie + Friends, a Canadian charity supporting children with juvenile arthritis and other rheumatic diseases, says roughly 25,000 children across the country are living with those conditions

Cassie + Friends is holding a Calgary run and walk at Fish Creek Park on Oct. 3, bringing families, doctors and supporters together to raise awareness and funds.

“The medication is great; that’s what treats a disease. But it’s really building this community around it is what lets the families really thrive together,” Porte said.

“We really want people to understand that kids get arthritis too. We really want people to understand what those symptoms are, what they should be looking for if their child has sore joints in the morning, if they’re complaining about pain, that not to overlook it.”

Porte adds that the community events his team runs across Canada are also a chance to build awareness.

One of the challenges is access to treatment.

“The access is not consistent across the country. The access is not consistent for all kids and families, so that is one of the other things that we’re really working on.”

Growing economic burden in Alberta

Arthritis Society Canada is also using Arthritis Awareness Month to highlight the broader impact of the disease.

According to the organization, arthritis carries an estimated $5.1-billion annual economic cost in Alberta through expenses such as medication and hospital care, as well as lost productivity.

Trish Barbato, president and CEO of Arthritis Society Canada, said the report shows another $10 billion is also attributed to social value loss.

“The social impact cost is a new number. It is related to what do people lose because they’re in pain all the time, because they don’t have mobility.”

The cost of pain, reduced mobility, lost independence and the activities people can no longer take part in means arthritis is now the leading cause of disability across Canada.

Barbato adds that the Alberta figures also show the consequences for both individuals and the health-care system.

“It’s a failing of the system. It’s not a failing of individuals who choose to find another path,” Barbato said when discussing the challenges faced by people trying to access arthritis care.

She says improving access to community-based therapy and education could also help people manage the disease and, in some cases, reduce pressure on the health-care system.

“And so when you think about someone who says, ‘I have a bad knee,’ I always joke, ‘You do not have a bad knee. You have end stage arthritis.’”

“If you’re not mobile, if you can’t walk, that is going to impact your job and your ability to be productive.”

The report projects the overall economic and social burden of arthritis in Canada will rise from $142.4 billion annually today to $222.3 billion by 2055, as the number of people living with the disease is expected to grow from more than six million to at least 10 million.

Primary Care Alberta says arthritis can significantly affect a person’s health, independence and quality of life, and that provincial guidance is available to help health-care providers assess and manage the condition.

It says Albertans can also access supports including arthritis education, physiotherapy, self-management workshops and exercise programs.

https://www.ctvnews.ca/calgary/article/calgary-boys-arthritis-diagnosis-highlights-a-disease-many-still-associate-only-with-old-age/ 

Friday, 19 June 2026

Western research could expand remote access to care for thumb arthritis

From news.westernu.ca

Professor Joy MacDermid leading project funded by Ignite Innovation Grant to provide more equitable care 

The burning, grinding pain of thumb arthritis disrupts daily life for one in four older adults in Canada. Thumb splints can reduce pain and improve hand function, and now, a Western University researcher in London, Ont. is working to bring custom 3D-printed splints to patients who can’t access specialist clinics.

Joy MacDermid, a physiotherapy professor in the Faculty of Health Sciences and a member of Western’s Bone and Joint Institute, received an Ignite Innovation Grant from the Arthritis Society of Canada to fund the second phase of her study. It will improve care for people with thumb arthritis, a condition that occurs when cartilage breaks down in the carpometacarpal joint at the base of the thumb, causing pain, stiffness and weakened grip.

“We see a lot of women over 50 with thumb arthritis, especially those doing physical work,” MacDermid said. “They struggle with daily activities like turning a key or caring for grandchildren.” 

The current standard of care requires a hand therapist to see the patient in person, assess their hand and mold a thermoplastic splint directly onto it. Though a proven process, it depends on physical proximity to a specialist clinic. MacDermid and her team are devising a new solution that doesn’t require in-person visits. 

Splints improve joint alignment in thumb arthritis

As co-director of the clinical research lab at Roth | McFarlane Hand & Upper Limb Centre (Roth | McFarlane) and a scientist at Lawson Research Institute (Lawson) of St. Joseph’s Health Care London, MacDermid leads researchers studying how to measure, predict and reduce upper extremity disability.    

Marjan Saeedi, a physical therapy PhD candidate, is part of the team at Roth | McFarlane. 

“Over time, the CMC joint becomes unstable and misaligned due to cartilage degeneration, affecting the ligaments and muscles as well. Because we use our thumbs constantly, the misalignment and pain worsens,” she said. “A splint helps support joint alignment. It’s even helpful following joint replacement surgery.”   

Western engineering professor and Lawson scientist Louis Ferreira led an earlier Mitacs-funded study with MacDermid and Belgian industry partner Orfit to develop a remote splint-making process using new materials and new 3D hand-scanning technology: an iPhone scanning app or a custom scanner developed in Ferreira’s bioengineering lab. Without the patient being present, the scans captured the precise measurements needed to fabricate 3D-printed custom splints.

MacDermid’s team also developed a clinical app to remotely assess a patient’s pain levels, hand function and splint requirements, replicating the intake process normally done in person. The prototypes made with the new process showed promise.  

“The question now is whether people can use the new methods in routine clinical practice,” MacDermid said. 

Implementing, testing the innovative thumb splint 

MacDermid is leading an Arthritis Society Ignite Grant evaluating how hand therapists use the new process and how patients respond to the 3D-printed splints compared to conventional ones. Her team hopes to scale up the new process by running workshops to train hand therapists at Roth | McFarlane and in community-based clinics across London, Ont. They’re also evaluating scanners that offer more precision than iPhone apps, without the cost of their custom device. 

examples of 3d-printed thumb splints in a top image contrasted with conventionally made thumb splints in the lower image

Patient wearing (top) 3D-printed thumb splints and (bottom) traditionally fabricated splints. (Submitted)

In the trial of the 3D-printed solution, patients receive both a traditionally fabricated splint and a digitally produced one, wearing each for six weeks while researchers assess hand strength, pain levels and patient preference.

“Most were really eager to try the 3D-printed version,” said Saeedi. “The perforations from the printing process improve air circulation, and female patients liked its smaller size and the option to choose the colour, making it like an accessory on their hand.” 

Saeedi is writing her dissertation on what makes patients adhere to consistent use of their splints. Pain relief and comfort top the list, though she has also documented a motivator outside of its main clinical use. 

“Patients say, ‘I can wear it when my grandchildren are around or on public transit, without worrying about pain or further injury if it gets bumped or jostled’,” Saeedi said. “That sense of protection helps keep them using it.” 

Addressing access barriers in thumb arthritis treatment 

The remotely designed, 3D-printed splint is not intended to replace traditional care, but to remove barriers to accessing care.   

“Some of our clients are driving from Owen Sound or Sarnia or Windsor, in the middle of winter,” MacDermid said. “In the future, if their splint gets damaged or their hand changes, we would be able to reprint it from the pattern in our system and mail it to them – no return trip needed.” 

Four researchers (L to R) Marjan Saeedi, PhD candidate, Maryam Farzad, postdoctoral student and co-principal investigator, Katrina Munro, research co-ordinator and Joy MacDermid, principal investigator working on a process for remotely-produced thumb splints.

(L to R) Western PhD candidate Marjan Saeedi; Western postdoctoral student and co-principal investigator, Maryam Farzad; research co-ordinator at the Roth | McFarlane Hand and Upper Limb Centre, Katrina Munro; and principal investigator and Western physiotherapy professor Joy MacDermid are part of a research team that aims to make 3D-printed thumb splints accessible to patients no matter where they live. (Colleen MacDonald/Western News)

The Ignite Grant includes funding for MacDermid’s team to adapt their process to make splints for patients recovering from surgery or injections to treat Dupuytren’s contracture, a separate hand condition that causes fingers to permanently bend inward due to thickening and shortening of connective tissue in the palm.  

MacDermid attributes the project’s success from the beginning to contributions from many grad students and postdoctoral scholars across faculties, including those Ferreira supervised. 

“This project is genuinely interdisciplinary. We simply can’t do the clinical work without the engineering, and vice versa,” she said. 

MacDermid says the future of the project could reach communities with some clinical infrastructure but no hand specialist. Going further still, with the help of AI-assisted remote scanning, the process would enable people in remote locations like the Arctic, with no local clinical support at all, to access custom splints.  

For now, the project is already attracting interest from therapists in other provinces who want to attend the workshops. 

“That would be a substantial accomplishment to spread a working clinical process across Canada,” MacDermid said. “This technology could make a real difference for people who currently aren’t getting care at all due to distance, disability or the absence of specialist care.” 

https://news.westernu.ca/2026/06/western-research-3d-printed-splints-thumb-arthritis/

Wednesday, 28 January 2026

World-renowned health economist builds “pathway to impact” for children with arthritis and their families

From cihr-irsc.gc.ca

“Most people don’t know that kids get arthritis,” says Dr. Deborah Marshall. “And they don’t understand the serious and wide-ranging effects of arthritis on child patients, their families, and communities.”

Dr. Marshall, Svare Chair, Health Economics, Value and Impact at the University of Calgary, studies the social and economic burden of juvenile arthritis and gathers data and evidence to influence health decision-making.

“In our research program, we are focused on standardizing measurements of care, measuring treatment preferences, and modelling the cost-effectiveness of personalized treatment strategies,” says Dr. Marshall. “Overall, we’re building a pathway to impact for better health and well-being for children and families.”

                                                                                               Dr. Deborah Marshall

Arthritis is one of the most common inflammatory diseases in childhood. It affects around 25,000 children in Canada. In juvenile arthritis, the immune system attacks the joints, causing pain, swelling, inflammation, and in many cases irreversible damage and long-term disability. The disease can have debilitating effects in all areas of a child‘s life.

The good news is that in the last decade a variety of treatment options have become available for children with arthritis. The gap is knowing which treatment will work optimally in each case.

Dr. Marshall with Cassie + Friends, a juvenile arthritis charity. (Photo credit : Cassie + Friends)

Dr. Marshall is the health economics lead for the successful national and international Understanding Childhood Arthritis Network (UCAN) collaboration. Through this collaboration, Dr. Marshall and her colleagues and partners are advancing science, generating knowledge, and have created a highly effective data collection and sharing ecosystem.

“It doesn’t sound very sexy, but we need to measure things,” says Dr. Marshall. “We need to be able to measure the outcomes and socioeconomic burden for patients—and we need data to tell our impact story and drive actionable change.”

Children with arthritis have a variety of treatment options. In Canada, treatments usually start with steroids, then move to a class of drugs named disease-modifying anti-rheumatic drugs, or DMARDS, and finally to biologics, which are expensive and may not be accessible, depending on where you live in the country. It can take a couple of years of trying different drugs before finding one that works best for the patient.

“It’s difficult to believe, that in the 21st century, we still use trial and error to arrive at the right drug,” says Dr. Rae Yeung, a paediatric rheumatologist, leader of the UCAN research program, and Scientific Director of the CIHR Institute of Musculoskeletal Health and Arthritis.

“With UCAN’s comprehensive data strategy, we can answer questions using data from multiple domains, including demographic, clinical, biologic, socioeconomic and patient reported outcomes. This wholistic approach allows us to develop personalized treatment plans for patients and may lead to cost savings for the health system and families.”

Most studies on juvenile arthritis have focused on medical costs. But what is often hidden are the significant social and economic costs for patients and their families. They include missing school and social activities, having to reduce work hours, and paying out-of-pocket for medications, physical therapy, and travel to see arthritis specialists in other cities.

Dr. Marshall and her team

“It’s heartbreaking to listen to patients and parents talk about the effect of arthritis on their lives,” says Dr. Marshall.

Listening to patients motivated Dr. Marshall and her team to develop research training opportunities and empower patients and their families.

Dr. Marshall is one of the founders of the Patient and Community Engagement Research (PaCER) program at the University of Calgary where participants learn how to design and implement qualitative research studies. A group of youth with arthritis who took the PaCER program conducted a study that filled an evidence gap on the experience of youth with arthritis in the transition from paediatric to adult care in Canada.

An international project led by Canada called PAVE (Producing an Arthritis Value-Framework with Economic Evidence) will develop an evidence-informed, patient and parent co-created framework that will fully capture all the ways that childhood arthritis affects families. Dr. Marshall is collaborating on PAVE with Cassie and Friends, a juvenile arthritis charity, which is the lead patient organization for the consortium.

The strong leadership of Dr. Marshall and her outstanding contributions to programs such as UCAN, PaCER, PAVE, and others helped secure the funding for One Child Every Child, a Canada-first research and translation initiative, which is supported by a major grant from the Canada First Research Excellence Fund.

Dr. Marshall also leads the value, impact and knowledge mobilization accelerator of One Child Every Child, which embeds value and impact measures into research activities to achieve maximum impact by design. With their destination clearly in mind, the team is well on the road to creating a healthier future for children in Canada and globally.

https://cihr-irsc.gc.ca/e/54595.html